Health needs, treatment decisions and experience of traditional complementary and integrative medicine use by women with diminished ovarian reserve: A cross-sectional survey.
diminished ovarian reserve
fertility
mental health
traditional complementary integrative medicine
women's experience
Journal
The Australian & New Zealand journal of obstetrics & gynaecology
ISSN: 1479-828X
Titre abrégé: Aust N Z J Obstet Gynaecol
Pays: Australia
ID NLM: 0001027
Informations de publication
Date de publication:
21 Mar 2024
21 Mar 2024
Historique:
received:
27
07
2023
accepted:
13
02
2024
medline:
22
3
2024
pubmed:
22
3
2024
entrez:
22
3
2024
Statut:
aheadofprint
Résumé
Women with diminished ovarian reserve (DOR) have fewer eggs than would be expected at their age. It is estimated that 10% of women seeking fertility treatment are diagnosed with DOR. However, the success rate of medically assisted reproduction (MAR) is significantly lower in women with DOR, thus many seek additional approaches. To explore the health needs of women with DOR, treatment options and experience of treatment including traditional complementary integrative medicine (TCIM). Anyone with a diagnosis of DOR, living in Australia or New Zealand, aged over 18 were invited to complete an online survey distributed via fertility support networks and social media platforms from April to December 2021. Data from 67 respondents were included. The main aspects of health that were impacted by DOR were fertility (91.0%) and mental health (52.2%). The main treatment recommended was MAR with most women either currently using MAR (38.8%) or having previously used MAR (37.3%). TCIM was widely used with 88.1% of women utilising supplements, 74.6% consulting with TCIM practitioners, and 65.7% adopting self-care practices. The main reasons for using TCIM were to improve fertility or support pregnancy, and to support general health and well-being. Women with DOR have additional health needs apart from infertility, most notably mental health support. The main form of treatment utilised is MAR, despite DOR being challenging for fertility clinicians. TCIM was widely used, and respondents perceived benefits related to improving fertility, supporting pregnancy, or improving well-being through use of acupuncture, meditation, naturopathy, massage, yoga.
Sections du résumé
BACKGROUND
BACKGROUND
Women with diminished ovarian reserve (DOR) have fewer eggs than would be expected at their age. It is estimated that 10% of women seeking fertility treatment are diagnosed with DOR. However, the success rate of medically assisted reproduction (MAR) is significantly lower in women with DOR, thus many seek additional approaches.
AIM
OBJECTIVE
To explore the health needs of women with DOR, treatment options and experience of treatment including traditional complementary integrative medicine (TCIM).
METHODS
METHODS
Anyone with a diagnosis of DOR, living in Australia or New Zealand, aged over 18 were invited to complete an online survey distributed via fertility support networks and social media platforms from April to December 2021.
RESULTS
RESULTS
Data from 67 respondents were included. The main aspects of health that were impacted by DOR were fertility (91.0%) and mental health (52.2%). The main treatment recommended was MAR with most women either currently using MAR (38.8%) or having previously used MAR (37.3%). TCIM was widely used with 88.1% of women utilising supplements, 74.6% consulting with TCIM practitioners, and 65.7% adopting self-care practices. The main reasons for using TCIM were to improve fertility or support pregnancy, and to support general health and well-being.
CONCLUSIONS
CONCLUSIONS
Women with DOR have additional health needs apart from infertility, most notably mental health support. The main form of treatment utilised is MAR, despite DOR being challenging for fertility clinicians. TCIM was widely used, and respondents perceived benefits related to improving fertility, supporting pregnancy, or improving well-being through use of acupuncture, meditation, naturopathy, massage, yoga.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Authors. Australian and New Zealand Journal of Obstetrics and Gynaecology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
Références
Cohen J, Chabbert‐Buffet N, Darai E. Diminished ovarian reserve, premature ovarian failure, poor ovarian responder—A plea for universal definitions. J Assist Reprod Genet 2015; 32(12): 1709–1712. https://doi.org/10.1007/s10815‐015‐0595‐y.
Levi AJ, Raynault MF, Bergh PA et al. Reproductive outcome in patients with diminished ovarian reserve. Fertil Steril 2001; 76(4): 666–669. https://doi.org/10.1016/S0015‐0282(01)02017‐9.
Lyttle Schumacher BM, Jukic AMZ, Steiner AZ. Antimüllerian hormone as a risk factor for miscarriage in naturally conceived pregnancies. Fertil Steril 2018; 109(6): 1065–1071.e1061. https://doi.org/10.1016/j.fertnstert.2018.01.039.
Artini PG, Ruggiero M, Uccelli A et al. Fertility management of patients with reduced ovarian reserve. Reprod Syst Sex Disord 2013; S5‐006. https://doi.org/10.4172/2161‐038X.S5‐006.
ASRM, Practice Committee of American Society for Reproductive Medicine. Diagnostic evaluation of the infertile female: A committee opinion. Fertil Steril 2012; 98(2): 302–307. https://doi.org/10.1016/j.fertnstert.2012.05.032.
Buckett W, Sierra S. The management of unexplained infertility: An evidence‐based guideline from the Canadian Fertility and Andrology Society. RBMO 2019; 39(4): 633–640. https://doi.org/10.1016/j.rbmo.2019.05.023.
Meng F, Goldsammler M, Wantman E, Jindal SK. Live birth rate is associated with infertility diagnosis following FET of chromosomally euploid blastocysts: Analysis of 5,633 cycles reported to sartcors. Fertil Steril 2017; 108(3): e280. https://doi.org/10.1016/j.fertnstert.2017.07.831.
Harris K, Burley H, McLachlan R et al. Socio‐economic disparities in access to assisted reproductive technologies in Australia. RBMO 2016; 33(5): 575–584. https://doi.org/10.1016/j.rbmo.2016.07.012.
Reid R, Steel A, Wardle J et al. Complementary medicine use by the Australian population: A critical mixed studies systematic review of utilisation, perceptions and factors associated with use. BMC Complement Altern Med 2016; 16(1): 176 https://doi.org/10.1186/s12906‐016‐1143‐8.
Rayner J, McLachlan H, Forster D, Cramer R. Australian women's use of complementary and alternative medicines to enhance fertility: Exploring the experiences of women and practitioners. BMC Complement Altern Med 2009; 9(1): 52. https://doi.org/10.1186/1472‐6882‐9‐52.
Steel A, Lucke J, Adams J. The prevalence and nature of the use of preconception services by women with chronic health conditions: An integrative review. BMC Womens Health 2015; 15(1): 14 https://doi.org/10.1186/s12905‐015‐0165‐6.
Steel A, Adams J, Sibbritt D. The characteristics of women who use complementary medicine while attempting to conceive: Results from a nationally representative sample of 13,224 Australian women. Womens Health Issues 2017; 27(1): 67–74. https://doi.org/10.1016/j.whi.2016.09.010.
Quandt SA, Verhoef MJ, Arcury TA et al. Development of an international questionnaire to measure use of complementary and alternative medicine (I‐CAM‐Q). J Altern Complement Med 2009; 15(4): 331–339. https://doi.org/10.1089/acm.2008.0521.
Qualtrics XM. [computer program]. Version v10.21. Provo, Utah, USA: Qualtrics, 2005.
IBM SPSS Statistics for Macintosh. [computer program]. Version 29.0. Armonk, NY: IBM Corp, 2021.
Zhu D, Chung HF, Dobson AJ et al. Age at natural menopause and risk of incident cardiovascular disease: A pooled analysis of individual patient data. Lancet Public Health 2019; 4(11): e553–e564. https://doi.org/10.1016/s2468‐2667(19)30155‐0.
Greene AD, Patounakis G, Segars JH. Genetic associations with diminished ovarian reserve: A systematic review of the literature. J Assist Reprod Genet 2014; 31(8): 935–946. https://doi.org/10.1007/s10815‐014‐0257‐5.
Korevaar TIM, Mínguez‐Alarcón L, Messerlian C et al. Association of thyroid function and autoimmunity with ovarian reserve in women seeking infertility care. Thyroid 2018; 28(10): 1349–1358. https://doi.org/10.1089/thy.2017.0582.
Peigné M, Decanter C. Serum AMH level as a marker of acute and long‐term effects of chemotherapy on the ovarian follicular content: A systematic review. Reprod Biol Endocrinol 2014; 12(1): 26. https://doi.org/10.1186/1477‐7827‐12‐26.
Torre A, Paillusson B, Fain V et al. Uterine artery embolization for severe symptomatic fibroids: Effects on fertility and symptoms. Hum Reprod 2014; 29(3): 490–501. https://doi.org/10.1093/humrep/det459.
Richardson MC, Guo M, Fauser BC, Macklon NS. Environmental and developmental origins of ovarian reserve. Hum Reprod Update 2014; 20(3): 353–369. https://doi.org/10.1093/humupd/dmt057.
Ding T, Yan W, Zhou T et al. Endocrine disrupting chemicals impact on ovarian aging: Evidence from epidemiological and experimental evidence. Environ Pollut 2022; 305: 119269. https://doi.org/10.1016/j.envpol.2022.119269.
Fallahzadeh H, Zareei Mahmood Abadi H, Momayyezi M et al. The comparison of depression and anxiety between fertile and infertile couples: A meta‐analysis study. Int J Reprod Biomed 2019; 17(3): 153–162. https://doi.org/10.18502/ijrm.v17i3.4514.
Nik Hazlina NH, Norhayati MN, Shaiful Bahari I, Nik Muhammad Arif NA. Worldwide prevalence, risk factors and psychological impact of infertility among women: A systematic review and meta‐analysis. BMJ Open 2022; 12(3): e057132. https://doi.org/10.1136/bmjopen‐2021‐057132.
Evans A, de Lacey S, Tremellen K. Australians' understanding of the decline in fertility with increasing age and attitudes towards ovarian reserve screening. Aust J Prim Health 2018; 24(5): 428–433. https://doi.org/10.1071/py18040.
ASRM. Testing and interpreting measures of ovarian reserve: A committee opinion. Fertil Steril 2020; 114(6): 1151–1157. https://doi.org/10.1016/j.fertnstert.2020.09.134.
Steiner AZ, Pritchard D, Stanczyk FZ et al. Association between biomarkers of ovarian reserve and infertility among older women of reproductive age. JAMA 2017; 318(14): 1367–1376. https://doi.org/10.1001/jama.2017.14588.
Zarek SM, Mitchell EM, Sjaarda LA et al. Antimüllerian hormone and pregnancy loss from the effects of aspirin in gestation and reproduction trial. Fertil Steril 2016; 105(4): 946–952.e942. https://doi.org/10.1016/j.fertnstert.2015.12.003.
Kushnir VA, Safdie M, Darmon SK et al. Age‐specific IVF outcomes in infertile women with baseline FSH levels ≥20 mIU/mL. Reprod Sci 2018; 25(6): 893–898. https://doi.org/10.1177/1933719117697130.
Lensen SF, Wilkinson J, Leijdekkers JA et al. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI). Cochrane Database Syst Rev 2018; 2(2): Cd012693. https://doi.org/10.1002/14651858.CD012693.pub2.
Turkgeldi E, Yildiz S, Cekic SG et al. Effectiveness of the flexible progestin primed ovarian stimulation protocol compared to the flexible GnRH antagonist protocol in women with decreased ovarian reserve. Hum Fertil (Camb) 2022; 25(2): 306–312. https://doi.org/10.1080/14647273.2020.1794060.
Steel A, McIntyre E, Harnett J et al. Complementary medicine use in the Australian population: Results of a nationally‐representative cross‐sectional survey. Sci Rep 2018; 8(1): 17325. https://doi.org/10.1038/s41598‐018‐35508‐y.
Veziari Y, Kumar S, Leach M. Barriers to the conduct and application of research among complementary and alternative medicine professions in Australia and New Zealand: A cross‐sectional survey. Complement Ther Med 2021; 60: 102752. https://doi.org/10.1016/j.ctim.2021.102752.
Wardle J, Steel A. Fertility, preconception care and pregnancy. In: Sarris J, Wardle J, eds. Clinical Naturopathy: An Evidence‐Based Guide to Practice. Chatswood: Elsevier, 2010.
Myers SP, Vigar V. The state of the evidence for whole‐system, multi‐modality naturopathic medicine: A systematic scoping review. J Altern Complement Med 2019; 25(2): 141–168. https://doi.org/10.1089/acm.2018.0340.
Steel A, Diezel H, Wardle J, Johnstone K. Patterns of interprofessional communication between complementary and conventional practitioners providing maternity care services: A preliminary examination of the perceptions of CAM practitioner. Aust J Herb Med 2013; 25(2): 57–61. https://doi.org/10.3316/informit.481776660866895.
Navin Cristina TJ, Stewart Williams JA, Parkinson L et al. Identification of diabetes, heart disease, hypertension and stroke in mid‐ and older‐aged women: Comparing self‐report and administrative hospital data records. Geriatr Gerontol Int 2016; 16(1): 95–102. https://doi.org/10.1111/ggi.12442.